BioSpace News Archive

Kodiak Sciences Inc., a clinical stage biopharmaceutical company developing novel therapeutics to treat chronic, high-prevalence retinal diseases, announced that management will present at the virtual Bank of America Merrill Lynch Health Care Conference on Wednesday, May 13, 2020 at 11:20 a.m. Pacific Time.

Intec Pharma Ltd. announces financial results for the first quarter ended March 31, 2020 and provides a corporate update.

Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced its financial results for the first quarter ended March 31, 2020.

Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced financial results for the quarter ended March 31, 2020.

Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary diagnostic company, today reported consolidated financial results for the first quarter ended March 31, 2020. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of America (“U.S. GAAP”).

Mustang Bio, Inc. announced financial results and recent corporate highlights for the first quarter ended March 31, 2020.

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today reported financial results for the first quarter ended March 31, 2020 and provided a corporate update.

AdaptHealth Corp., a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, announced that management will present at the following virtual healthcare conferences in May:

ESCAPE Bio, Inc., a precision neurology company, today announced that Julie Anne Smith, Chief Executive Officer, will present at the Bank of America Securities Virtual Health Care Conference on Thursday, May 14th at 1:40 p.m. Eastern Time.

Unum Therapeutics Inc. (NASDAQ: UMRX), a biopharmaceutical company focused on developing curative cell therapies for solid tumors, today announced financial results for the first quarter ended March 31, 2020, and provided corporate updates.